BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 16847285)

  • 1. A serum glycomics approach to breast cancer biomarkers.
    Kirmiz C; Li B; An HJ; Clowers BH; Chew HK; Lam KS; Ferrige A; Alecio R; Borowsky AD; Sulaimon S; Lebrilla CB; Miyamoto S
    Mol Cell Proteomics; 2007 Jan; 6(1):43-55. PubMed ID: 16847285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles.
    Kyselova Z; Mechref Y; Kang P; Goetz JA; Dobrolecki LE; Sledge GW; Schnaper L; Hickey RJ; Malkas LH; Novotny MV
    Clin Chem; 2008 Jul; 54(7):1166-75. PubMed ID: 18487288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A glycomics approach to the discovery of potential cancer biomarkers.
    An HJ; Lebrilla CB
    Methods Mol Biol; 2010; 600():199-213. PubMed ID: 19882130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring serum and immunoglobulin G N-glycome as diagnostic biomarkers for early detection of breast cancer in Ethiopian women.
    Gebrehiwot AG; Melka DS; Kassaye YM; Gemechu T; Lako W; Hinou H; Nishimura SI
    BMC Cancer; 2019 Jun; 19(1):588. PubMed ID: 31208374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycomics analysis of serum: a potential new biomarker for ovarian cancer?
    Leiserowitz GS; Lebrilla C; Miyamoto S; An HJ; Duong H; Kirmiz C; Li B; Liu H; Lam KS
    Int J Gynecol Cancer; 2008; 18(3):470-5. PubMed ID: 17655680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls.
    Kawaguchi-Sakita N; Kaneshiro-Nakagawa K; Kawashima M; Sugimoto M; Tokiwa M; Suzuki E; Kajihara S; Fujita Y; Iwamoto S; Tanaka K; Toi M
    Biochem Biophys Res Commun; 2016 Jan; 469(4):1140-5. PubMed ID: 26740182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative O-glycomics based on improvement of the one-pot method for nonreductive O-glycan release and simultaneous stable isotope labeling with 1-(d
    Wang C; Zhang P; Jin W; Li L; Qiang S; Zhang Y; Huang L; Wang Z
    J Proteomics; 2017 Jan; 150():18-30. PubMed ID: 27585995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum N-glycan profiles differ for various breast cancer subtypes.
    Vreeker GCM; Vangangelt KMH; Bladergroen MR; Nicolardi S; Mesker WE; Wuhrer M; van der Burgt YEM; Tollenaar RAEM
    Glycoconj J; 2021 Jun; 38(3):387-395. PubMed ID: 33877489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression.
    Holst S; Deuss AJ; van Pelt GW; van Vliet SJ; Garcia-Vallejo JJ; Koeleman CA; Deelder AM; Mesker WE; Tollenaar RA; Rombouts Y; Wuhrer M
    Mol Cell Proteomics; 2016 Jan; 15(1):124-40. PubMed ID: 26537799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycoproteomic analyses of ovarian cancer cell lines and sera from ovarian cancer patients show distinct glycosylation changes in individual proteins.
    Li B; An HJ; Kirmiz C; Lebrilla CB; Lam KS; Miyamoto S
    J Proteome Res; 2008 Sep; 7(9):3776-88. PubMed ID: 18642944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-mannose glycans are elevated during breast cancer progression.
    de Leoz ML; Young LJ; An HJ; Kronewitter SR; Kim J; Miyamoto S; Borowsky AD; Chew HK; Lebrilla CB
    Mol Cell Proteomics; 2011 Jan; 10(1):M110.002717. PubMed ID: 21097542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting glycan cancer biomarkers in serum samples using MALDI FT-ICR mass spectrometry data.
    Barkauskas DA; An HJ; Kronewitter SR; de Leoz ML; Chew HK; de Vere White RW; Leiserowitz GS; Miyamoto S; Lebrilla CB; Rocke DM
    Bioinformatics; 2009 Jan; 25(2):251-7. PubMed ID: 19073586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer.
    An HJ; Miyamoto S; Lancaster KS; Kirmiz C; Li B; Lam KS; Leiserowitz GS; Lebrilla CB
    J Proteome Res; 2006 Jul; 5(7):1626-35. PubMed ID: 16823970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycomic approach for potential biomarkers on prostate cancer: profiling of N-linked glycans in human sera and pRNS cell lines.
    de Leoz ML; An HJ; Kronewitter S; Kim J; Beecroft S; Vinall R; Miyamoto S; de Vere White R; Lam KS; Lebrilla C
    Dis Markers; 2008; 25(4-5):243-58. PubMed ID: 19126968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative profiling of N-glycans isolated from serum samples of ovarian cancer patients and analyzed by microchip electrophoresis.
    Mitra I; Alley WR; Goetz JA; Vasseur JA; Novotny MV; Jacobson SC
    J Proteome Res; 2013 Oct; 12(10):4490-6. PubMed ID: 23984816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer diagnosis by analysis of serum N-glycans using MALDI-TOF mass spectroscopy.
    Lee SB; Bose S; Ahn SH; Son BH; Ko BS; Kim HJ; Chung IY; Kim J; Lee W; Ko MS; Lee K; Chang S; Park HS; Lee JW; Kim DC
    PLoS One; 2020; 15(4):e0231004. PubMed ID: 32271809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative serum glycomics of esophageal adenocarcinoma and other esophageal disease onsets.
    Mechref Y; Hussein A; Bekesova S; Pungpapong V; Zhang M; Dobrolecki LE; Hickey RJ; Hammoud ZT; Novotny MV
    J Proteome Res; 2009 Jun; 8(6):2656-66. PubMed ID: 19441788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Mass Spectrometry Platform for Multiplexed N-Glycoprotein Biomarker Discovery from Patient Biofluids by Antibody Panel Based N-Glycan Imaging.
    Black AP; Liang H; West CA; Wang M; Herrera HP; Haab BB; Angel PM; Drake RR; Mehta AS
    Anal Chem; 2019 Jul; 91(13):8429-8435. PubMed ID: 31177770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum glycan signatures of gastric cancer.
    Ozcan S; Barkauskas DA; Renee Ruhaak L; Torres J; Cooke CL; An HJ; Hua S; Williams CC; Dimapasoc LM; Han Kim J; Camorlinga-Ponce M; Rocke D; Lebrilla CB; Solnick JV
    Cancer Prev Res (Phila); 2014 Feb; 7(2):226-35. PubMed ID: 24327722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable isotopic labeling-based quantitative targeted glycomics (i-QTaG).
    Kim KJ; Kim YW; Kim YG; Park HM; Jin JM; Hwan Kim Y; Yang YH; Kyu Lee J; Chung J; Lee SG; Saghatelian A
    Biotechnol Prog; 2015; 31(3):840-8. PubMed ID: 25832445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.